Logo image of UPXI

UPEXI INC (UPXI) Stock Fundamental Analysis

USA - NASDAQ:UPXI - US39959A2050 - Common Stock

6.0909 USD
-0.16 (-2.55%)
Last: 10/15/2025, 11:38:09 AM
Fundamental Rating

2

Overall UPXI gets a fundamental rating of 2 out of 10. We evaluated UPXI against 36 industry peers in the Personal Care Products industry. UPXI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. UPXI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year UPXI has reported negative net income.
UPXI had a negative operating cash flow in the past year.
UPXI had negative earnings in 4 of the past 5 years.
In multiple years UPXI reported negative operating cash flow during the last 5 years.
UPXI Yearly Net Income VS EBIT VS OCF VS FCFUPXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -11.05%, UPXI is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
UPXI has a Return On Equity (-15.19%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.05%
ROE -15.19%
ROIC N/A
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
UPXI Yearly ROA, ROE, ROICUPXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

1.3 Margins

With a Gross Margin value of 68.74%, UPXI perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Gross Margin of UPXI has grown nicely.
UPXI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
UPXI Yearly Profit, Operating, Gross MarginsUPXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

UPXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UPXI has more shares outstanding
Compared to 5 years ago, UPXI has more shares outstanding
The debt/assets ratio for UPXI has been reduced compared to a year ago.
UPXI Yearly Shares OutstandingUPXI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
UPXI Yearly Total Debt VS Total AssetsUPXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

UPXI has an Altman-Z score of 5.89. This indicates that UPXI is financially healthy and has little risk of bankruptcy at the moment.
UPXI has a Altman-Z score of 5.89. This is amongst the best in the industry. UPXI outperforms 86.11% of its industry peers.
UPXI has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of UPXI (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 5.89
ROIC/WACCN/A
WACC8.44%
UPXI Yearly LT Debt VS Equity VS FCFUPXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

2.3 Liquidity

A Current Ratio of 1.74 indicates that UPXI should not have too much problems paying its short term obligations.
UPXI's Current ratio of 1.74 is in line compared to the rest of the industry. UPXI outperforms 44.44% of its industry peers.
A Quick Ratio of 1.71 indicates that UPXI should not have too much problems paying its short term obligations.
UPXI has a better Quick ratio (1.71) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.71
UPXI Yearly Current Assets VS Current LiabilitesUPXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.38% over the past year.
Looking at the last year, UPXI shows a very negative growth in Revenue. The Revenue has decreased by -70.36% in the last year.
The Revenue has been growing by 16.37% on average over the past years. This is quite good.
EPS 1Y (TTM)69.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.37%
Revenue 1Y (TTM)-70.36%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%112.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y103.26%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year147.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UPXI Yearly Revenue VS EstimatesUPXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
UPXI Yearly EPS VS EstimatesUPXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UPXI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 199.05, UPXI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UPXI is on the same level as its industry peers.
UPXI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE N/A
Fwd PE 199.05
UPXI Price Earnings VS Forward Price EarningsUPXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UPXI Per share dataUPXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates UPXI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UPXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPEXI INC

NASDAQ:UPXI (10/15/2025, 11:38:09 AM)

6.0909

-0.16 (-2.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)09-24 2025-09-24/amc
Earnings (Next)12-18 2025-12-18
Inst Owners46.96%
Inst Owner Change0.01%
Ins Owners6.91%
Ins Owner Change0.09%
Market Cap358.69M
Analysts82.5
Price Target15.81 (159.57%)
Short Float %30.73%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-36.72%
Min Revenue beat(2)-82.88%
Max Revenue beat(2)9.44%
Revenue beat(4)1
Avg Revenue beat(4)-56.02%
Min Revenue beat(4)-82.88%
Max Revenue beat(4)9.44%
Revenue beat(8)1
Avg Revenue beat(8)-75.73%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)133.33%
EPS NY rev (3m)133.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)53.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 199.05
P/S 22.69
P/FCF N/A
P/OCF N/A
P/B 3.98
P/tB 10.87
EV/EBITDA N/A
EPS(TTM)-5.91
EYN/A
EPS(NY)0.03
Fwd EY0.5%
FCF(TTM)-1.93
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.27
BVpS1.53
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.05%
ROE -15.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.74%
FCFM N/A
ROA(3y)-46.06%
ROA(5y)-26.35%
ROE(3y)-146%
ROE(5y)-86.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.17%
GM growth 5Y14.66%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13895.3%
Cap/Sales 665.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.71
Altman-Z 5.89
F-Score5
WACC8.44%
ROIC/WACCN/A
Cap/Depr(3y)4646.3%
Cap/Depr(5y)2855.28%
Cap/Sales(3y)223.57%
Cap/Sales(5y)140.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.37%
EPS Next Y103.26%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-70.36%
Revenue growth 3Y-11.83%
Revenue growth 5Y16.37%
Sales Q2Q%112.77%
Revenue Next Year147.95%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10898.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8206.71%
OCF growth 3YN/A
OCF growth 5YN/A